Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network

OBJECTIVES: In lupus nephritis the pathological diagnosis from tissue retrieved during kidney biopsy drives treatment and management. Despite recent approval of new drugs, complete remission rates remain well under aspirational levels, necessitating identification of new therapeutic targets by great...

Descripción completa

Detalles Bibliográficos
Autores principales: Deonaraine, Kristina K, Carlucci, Philip M, Fava, Andrea, Li, Jessica, Wofsy, David, James, Judith A, Putterman, Chaim, Diamond, Betty, Davidson, Anne, Fine, Derek M, Monroy-Trujillo, Jose, Atta, Mohamed G, Haag, Kristin, Rao, Deepak A, Apruzzese, William, Belmont, H Michael, Izmirly, Peter M, Wu, Ming, Connery, Sean, Payan-Schober, Fernanda, Furie, Richard A, Berthier, Celine C, Dall'Era, Maria, Cho, Kerry, Kamen, Diane L, Kalunian, Kenneth, Anolik, Jennifer, Ishimori, Mariko, Weisman, Michael H, Petri, Michelle A, Buyon, Jill P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Lupus Nephritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354250/
https://www.ncbi.nlm.nih.gov/pubmed/34389634
http://dx.doi.org/10.1136/lupus-2021-000522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354250/
https://www.ncbi.nlm.nih.gov/pubmed/34389634
http://dx.doi.org/10.1136/lupus-2021-000522

Ejemplares similares